Zepbound vs Wegovy: which works better and which is easier to get online?

Short answer

• On average, Zepbound (tirzepatide) produces larger weight losses in clinical trials than Wegovy (semaglutide).
• Wegovy/semaglutide (and semaglutide products like Ozempic) are generally easier to find through large telehealth services; Zepbound/tirzepatide is becoming more available online but may be harder to get and less likely to be covered by insurance at first.

Key differences (quick)

• Drug class / mechanism: Wegovy = semaglutide (GLP‑1 receptor agonist). Zepbound = tirzepatide (dual GIP + GLP‑1 agonist). The dual action is believed to drive greater average weight loss and stronger blood‑sugar effects.
• Efficacy: Head‑to‑head and separate trials show tirzepatide tends to produce bigger mean weight reductions than semaglutide at comparable treatment durations. Individual response varies, though—some people do better with one drug than the other.
• Side effects: Both cause GI symptoms (nausea, diarrhea, constipation, vomiting). Titration schedules are used for both to reduce side effects. Safety considerations (pancreatitis history, personal/family history of medullary thyroid carcinoma or MEN2, pregnancy) are similar—discuss with a clinician.
• Dosing: Both are once‑weekly injectable medications with multi‑week dose escalation.

Availability and getting them online

• Wegovy (semaglutide) has been widely offered by telehealth weight‑loss services and many primary‑care telehealth platforms (and some prescribers use Ozempic off‑label for weight loss). Because it’s been on the market longer, it’s generally easier to find online—although Wegovy brand supply has experienced shortages at times.
• Zepbound (tirzepatide) is newer for weight management and initially may be harder to obtain. Many telehealth companies are adding tirzepatide options, but availability and insurance coverage can be more limited early on.

Reputable telehealth services that commonly prescribe GLP‑1s (examples)

• Calibrate — focuses on medically supervised metabolic weight‑loss programs, includes medication plus coaching. Good if you want structured program + prescribing.
• Hims & Hers (Hers Health) — widely used, convenient telehealth visits and prescription fulfillment for semaglutide and increasingly tirzepatide.
• Ro (formerly Roman) — offers weight‑loss telehealth services and can prescribe semaglutide/tirzepatide where appropriate.
• PlushCare — primary‑care–style telehealth that can evaluate/issue prescriptions and often works with major insurers.
• Your regular PCP or an endocrinologist — may be best for complex medical histories and for getting insurance coverage.

Safety/coverage/cost considerations

• Both are prescription drugs and require medical evaluation. Don’t buy from unverified overseas or black‑market sites.
• Insurance coverage varies widely; prior authorization is common. Wegovy may be covered by some plans; tirzepatide coverage will vary and may be limited early on. Expect high out‑of‑pocket costs if uninsured.
• Discuss pregnancy plans, pancreatic issues, thyroid cancer risks, and other medications with the prescriber.

What I recommend you do next

1. Talk with your primary care doctor or a reputable telehealth service (Calibrate, PlushCare, Hims/Hers, Ro) to review medical history and insurance.
2. Ask about both drugs (what they’ve had success with for people like you), expected side effects, program support (coaching, nutrition), and likely cost/coverage.
3. If you have complex medical issues (diabetes, prior pancreatitis, thyroid cancer risk), consider referral to an endocrinologist.

If you want, tell me: your age, major medical conditions, and whether you prefer a program with coaching vs. a simple prescription, and I can suggest the best place to start and how to approach coverage/price checks.